Kestra Medical Technologies Ltd. Statistics
Want to see KMTS full AI Analyst Report?
Kestra Medical Technologies Ltd. (KMTS) Stock Statistics & Valuation Metrics
Total Valuation
Kestra Medical Technologies Ltd. has a market cap or net worth of $1.71B. The enterprise value is $1.21B.
- Market Cap
- $1.71B
- Enterprise Value
- $1.21B
Share Statistics
Kestra Medical Technologies Ltd. has 59,561,794 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 59,561,794
- Owned by Insiders
- 43.97%
- Owned by Institutions
- 43.75%
Financial Efficiency
Kestra Medical Technologies Ltd.’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -43.73%.
- Return on Equity (ROE)
- -0.51
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -43.73%
- Return on Capital Employed (ROCE)
- -0.44
- Revenue Per Employee
- 214.73K
- Profits Per Employee
- -297.09K
- Employee Count
- 443
- Asset Turnover
- 0.27
- Inventory Turnover
- 6.90
Valuation Ratios
The current PE Ratio of Kestra Medical Technologies Ltd. is -10.73. Kestra Medical Technologies Ltd.’s PEG ratio is -0.68.
- PE Ratio
- -10.73
- PS Ratio
- 15.98
- PB Ratio
- 7.54
- Price to FCF
- -13.89
- Price to Operating Cash Flow
- -19.12
- PEG Ratio
- -0.68
Income Statement
In the last 12 months, Kestra Medical Technologies Ltd. had revenue of 95.13M and earned -131.61M in profits. Earnings per share was -2.43.
- Revenue
- 95.13M
- Gross Profit
- 48.86M
- Operating Income
- -134.74M
- Pretax Income
- -131.32M
- Net Income
- -131.61M
- EBITDA
- -136.93M
- Earnings Per Share (EPS)
- -2.43
Cash Flow
In the last 12 months, operating cash flow was -87.72M and capital expenditures -35.06M, giving a free cash flow of -122.78M billion.
- Operating Cash Flow
- -87.72M
- Free Cash Flow
- -122.78M
- Free Cash Flow per Share
- -2.10
Dividends & Yields
Kestra Medical Technologies Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.20%
- Earnings Yield
- -8.94%
Stock Price Statistics
- Beta
- 1.21
- 52-Week Price Change
- 14.97%
- 50-Day Moving Average
- 27.38
- 200-Day Moving Average
- 24.07
- Relative Strength Index (RSI)
- 49.45
- Average Volume (3m)
- 411.62K
Important Dates
Kestra Medical Technologies Ltd. upcoming earnings date is Dec 10, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 14, 2026
- Next Earnings Date
- Dec 10, 2026
- Ex-Dividend Date
- ―
Financial Position
Kestra Medical Technologies Ltd. as a current ratio of 4.41, with Debt / Equity ratio of 18.02%
- Current Ratio
- 4.41
- Quick Ratio
- 4.28
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.39
- Interest Coverage Ratio
- -17.85
Taxes
In the past 12 months, Kestra Medical Technologies Ltd. has paid 294.00K in taxes.
- Income Tax
- 294.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Kestra Medical Technologies Ltd. EV to EBITDA ratio is -13.11, with an EV/FCF ratio of -13.96.
- EV to Sales
- 16.06
- EV to EBITDA
- -13.11
- EV to Free Cash Flow
- -13.96
- EV to Operating Cash Flow
- -19.54
Balance Sheet
Kestra Medical Technologies Ltd. has $198.91M in cash and marketable securities with $76.45M in debt, giving a net cash position of $122.47M billion.
- Cash & Marketable Securities
- $198.91M
- Total Debt
- $76.45M
- Net Cash
- $122.47M
- Net Cash Per Share
- $2.06
- Tangible Book Value Per Share
- $3.80
Margins
Gross margin is 53.89%, with operating margin of -134.48%, and net profit margin of -140.43%.
- Gross Margin
- 53.89%
- Operating Margin
- -134.48%
- Pretax Margin
- -140.14%
- Net Profit Margin
- -140.43%
- EBITDA Margin
- -122.51%
- EBIT Margin
- -131.27%
Analyst Forecast
The average price target for Kestra Medical Technologies Ltd. is $30.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $30.60
- Price Target Upside
- 6.84% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 60.72%
- EPS Growth Forecast
- -5.66%
Scores
- Smart Score
- 2
- AI Score
- 55

